Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study

BACKGROUND: Rising resistance of HIV-1 to non-nucleoside reverse transcriptase inhibitors (NNRTIs) threatens the success of the global scale-up of antiretroviral therapy (ART). The switch to WHO-recommended dolutegravir (DTG)-based regimens could reduce this threat due to DTG’s high genetic barrier...

Descripción completa

Detalles Bibliográficos
Autores principales: Hauser, Anthony, Kusejko, Katharina, Johnson, Leigh F., Günthard, Huldrych F., Riou, Julien, Wandeler, Gilles, Egger, Matthias, Kouyos, Roger D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735592/
https://www.ncbi.nlm.nih.gov/pubmed/33315863
http://dx.doi.org/10.1371/journal.pmed.1003397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7735592/
https://www.ncbi.nlm.nih.gov/pubmed/33315863
http://dx.doi.org/10.1371/journal.pmed.1003397

Ejemplares similares